Abstract: The present invention refers a thermal insulation waterproofing and adherible film and method for preparing the same, that for its components and physical and chemical characteristics is easy to apply, durable, and with excellent insulation and waterproofing properties. The adherible film of the present invention is manufactured by applying insulating and waterproofing material on a layer of thermoplastic polymer, preferably polyethylene. In present invention were used different thicknesses, such as 1.2, 1.5, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2 and 4.4 mm, and according to tests carried out, the preferred modality that comply the requirements is 2.8 to 3.0 millimeters.

Abstract: The present invention refers a thermal insulation waterproofing and adherible film and method for preparing the same, that for its components and physical and chemical characteristics is easy to apply, durable, and with excellent insulation and waterproofing properties. The adherible film of the present invention is manufactured by applying insulating and waterproofing material on a layer of thermoplastic polymer, preferably polyethylene. In present invention were used different thicknesses, such as 1.2, 1.5, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2 and 4.4 mm, and according to tests carried out, the preferred modality that comply the requirements is 2.8 to 3.0 millimeters.

Abstract: Provided herein are compounds of formula (I) as well as compounds of formula (I) which are prodrugs in which the (R7)a-phenyl-S(O)2NH group represents a sulphonamide-bond compound, compositions and methods for preventing or treating gastrointestinal diseases such as inflammatory bowel disease and colorectal cancer, wherein the method comprises delivering an effective amount of a COX-2 or a similar sulphonamide inhibitor as a prodrug or a derivative thereof to the colon, wherein the COX-2 or similar inhibitor is released in vivo.

Abstract: Provided herein are compounds, compositions and methods for decreasing NF?B DNA-binding activity in a patient comprising administering of a therapeutically effective amount of a compound or composition of the application to the patient to reduce, alleviate or treat various gastrointestinal diseases, such as inflammatory bowel disease (IBD).